The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Measurement of endocrine activity (SET2,3) related to prognosis and prediction of benefit from dose-dense (DD) chemotherapy in estrogen receptor-positive (ER+) cancer: CALGB 9741 (Alliance).
 
Otto Metzger
Stock and Other Ownership Interests - Invitae
Honoraria - Grupo Oncoclinicas; Merck
Consulting or Advisory Role - Alliance for Clinical Trials in Oncology; Grupo Oncoclinicas; Resilience Care
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie (Inst); Cascadian Therapeutics (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst); Susan G. Komen for the Cure (Inst)
Patents, Royalties, Other Intellectual Property - Sanofi (Inst)
Travel, Accommodations, Expenses - Grupo Oncoclinicas
 
Karla V. Ballman
Consulting or Advisory Role - Agenus; Medtronic; Takeda
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Janssen Oncology; Lilly; Sanofi
 
Jordan Campbell
No Relationships to Disclose
 
Minetta C. Liu
Research Funding - Eisai (Inst); Exact Sciences (Inst); Genomic Health (Inst); GRAIL (Inst); Menarini Silicon Biosystems (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Genomic Health; GRAIL; Menarini Silicon Biosystems; Merck; Pfizer
 
Jennifer A. Ligibel
No Relationships to Disclose
 
Eveline Chen
No Relationships to Disclose
 
Lili Du
No Relationships to Disclose
 
W. Fraser Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; Eiger BioPharmaceuticals; ISIS Pharmaceuticals
Consulting or Advisory Role - Merck
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
(OPTIONAL) Uncompensated Relationships - Delphi Diagnostics